
Solvay Pharma India Limited
About Solvay Pharma India Limited
Data last updated:
Solvay Pharma India Limited was a public limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 January 2000.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN L24200MH2000PLC123813. It is recorded as listed by MCA, but its shares were delisted from BSE, and no longer trade on a stock exchange.
The company had an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹5.05 Cr. It was led by directors including Mohinderjit Singh Grewal and Duraiswamy Gunaseela Rajan.
Its last annual general meeting (AGM) was held on 18 April 2011, and its latest financial statements are for the year ended 31 December 2010. The registered office was at 271 Business Park, Mumbai, Maharashtra.
Court records list 21 cases involving the company, including 15 filed by the company and 6 filed against it; 2 cases are pending. The company has 1 deal on record (1 acquisition); the latest was in November 2009.
Company details
CIN history
Solvay Pharma India has one previous CIN (Corporate Identification Number): U24200MH2000PLC123813. The current CIN is L24200MH2000PLC123813, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24200MH2000PLC123813 | Current |
| U24200MH2000PLC123813 | Previous |
Contact details
Solvay Pharma India Limited's registered office is in Mumbai, Maharashtra.
- Registered Address271 Business Park 6th And 7th Floors Model Industrial Colony Off Aarey Road Goreg, Aon (E), Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Solvay Pharma India Limited
FY 2010 filings availableFinancial Statement Summary
| Metrics | FY 2009-10 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2009-10 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Solvay Pharma India Limited, buy the company report.
Board of directors of Solvay Pharma India Limited
Solvay Pharma India has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohinderjit Singh Grewal | Director | 21 Jul 2004 | 22 Years 3 Months | As last reported |
| Duraiswamy Gunaseela Rajan | Director | 24 Apr 2000 | 26 Years 6 Months | As last reported |
| Roland Wolfgang Kaut | Director | 06 Mar 2003 | 23 Years 8 Months | As last reported |
| Suresh Narsappa Talwar Also directs: True North Fund V LLP, True North Fund VI LLP, True North Trusteeship Private Limited and 1 more | Director | 16 Oct 2001 | 25 Years 1 Months | As last reported |
Deals & funding
Solvay Pharma India Limited has 1 deal on record (1 acquisition); the latest was in November 2009.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2009 | Acquisition | ₹831.09 Cr | Buyer: Abbott India Limited Seller: Solvay Healthcare Ltd. |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Solvay Pharma India Limited has 21 court cases on record: 15 filed by Solvay Pharma India, 6 filed against it. 2 cases are pending and 19 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 2 | 0 |
| High courts | 8 | 4 | 2 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by PR. Commissioner of Income Tax-2 | Pending |
| Bombay High Court | Writ petition | Filed against the company | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by State Governments | Disposed |
| District court, Kokrajhar, Assam | Civil suit | Filed against the company by State Bank of India | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Solvay Pharma India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solvay Pharma India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Solvay Pharma India Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Solvay Pharma India Limited has 14 board changes on record since 2000: 9 appointments and 5 cessations. The latest: Niteen B Gadgil ceased to be Managing Director on 01 Jul 2011.
5 earlier events are in the company report.
Frequently asked questions
Solvay Pharma India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Solvay Pharma India was a public limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 24 January 2000 and is registered under CIN L24200MH2000PLC123813. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Solvay Pharma India was incorporated on 24 January 2000. It is registered with the Registrar of Companies, Mumbai.
Solvay Pharma India had 4 directors:
- Mohinderjit Singh Grewal - Director
- Duraiswamy Gunaseela Rajan - Director
- Roland Wolfgang Kaut - Director
- Suresh Narsappa Talwar - Director
The CIN (Corporate Identification Number) of Solvay Pharma India is L24200MH2000PLC123813. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solvay Pharma India is recorded as a listed company by MCA, but its shares were delisted from BSE, and no longer trade on a stock exchange.
The registered office of Solvay Pharma India is at 271 Business Park 6th And 7th Floors Model Industrial Colony Off Aarey Road Goreg, Aon E, Mumbai, Maharashtra, India – 400063.
The latest financial statements of Solvay Pharma India on record with the MCA are for the year ended 31 December 2010. Its last annual general meeting was held on 18 April 2011. Year-wise statements from 2015 are in the company report.
Solvay Pharma India operated in the pharma industry, in the drug formulation and development segment.
Solvay Pharma India has 1 deal on record (1 acquisition); the latest was in November 2009.

